SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $418,000 | +45.6% | 3,780 | -1.1% | 0.05% | +50.0% |
| Q2 2022 | $287,000 | -61.4% | 3,823 | -59.8% | 0.03% | -57.0% |
| Q1 2022 | $743,000 | +118.5% | 9,511 | +151.6% | 0.08% | +113.5% |
| Q4 2021 | $340,000 | -63.3% | 3,780 | -62.3% | 0.04% | -65.1% |
| Q3 2021 | $927,000 | +165.6% | 10,021 | +123.0% | 0.11% | +178.9% |
| Q2 2021 | $349,000 | +1.7% | 4,493 | -2.3% | 0.04% | -7.3% |
| Q1 2021 | $343,000 | -85.5% | 4,599 | -66.9% | 0.04% | -88.3% |
| Q4 2020 | $2,367,000 | +47.4% | 13,886 | +21.4% | 0.35% | +29.7% |
| Q3 2020 | $1,606,000 | -23.6% | 11,439 | -12.7% | 0.27% | -25.9% |
| Q2 2020 | $2,101,000 | +158.1% | 13,102 | +57.4% | 0.36% | +132.7% |
| Q1 2020 | $814,000 | -5.0% | 8,323 | +25.3% | 0.16% | +27.9% |
| Q4 2019 | $857,000 | +242.8% | 6,640 | +100.1% | 0.12% | +205.0% |
| Q3 2019 | $250,000 | -77.8% | 3,318 | -55.2% | 0.04% | -77.9% |
| Q2 2019 | $1,124,000 | +231.6% | 7,400 | +160.4% | 0.18% | +212.1% |
| Q1 2019 | $339,000 | – | 2,842 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |